Methods for the Acylation of Maytansinol
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/705,731, filed Sep 26, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,012,629 | Methods for the Acylation of Maytansinol In force · High confidence UsedRemaining | ImmunoGen, Inc. | In force | High confidence | ||
| US 9,469,655 | Methods for the Acylation of Maytansinol In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 9,796,731 | Methods for the Acylation of Maytansinol In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 10,100,062 | Methods for the Acylation of Maytansinol In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 10,461,449 | Methods for the Acylation of Maytansinol In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 10,944,190 | Methods for the Acylation of Maytansinol In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| Application 17/732,953 | Methods for the Acylation of Maytansinol Abandoned Abandoned Oct 7, 2022 | ImmunoGen, Inc. | Abandoned | Abandoned Oct 7, 2022 | ||
| Application 17/938,119 | Methods for the Acylation of Maytansinol Abandoned Abandoned Jun 21, 2023 | ImmunoGen, Inc. | Abandoned | Abandoned Jun 21, 2023 | ||
| Application 18/130,707 | Methods for the Acylation of Maytansinol Abandoned Abandoned Dec 8, 2023 | ImmunoGen, Inc. | Abandoned | Abandoned Dec 8, 2023 | ||
| Application 18/242,321 | Methods for the Acylation of Maytansinol Abandoned Abandoned Jan 22, 2024 | ImmunoGen, Inc. | Abandoned | Abandoned Jan 22, 2024 | ||
| 2 more records in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
6 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.